Literature DB >> 19378260

Lasp1 misexpression influences chondrocyte differentiation in the vertebral column.

Natascha Hermann-Kleiter1, Nassim Ghaffari-Tabrizi, Michael J F Blumer, Christoph Schwarzer, Magdalena A Mazur, Isabella Artner.   

Abstract

The mouse mutant wavy tail Tg(Col1a1-lacZ)304ng was created through transgene insertion and exhibits defects of the vertebral column. Homozygous mutant animals have compressed tail vertebrae and wedge-shaped intervertebral discs, resulting in a meandering tail. Delayed closure of lumbar neural arches and lack of processus spinosi have been observed; these defects become most prominent during the transition from cartilage to bone. The spina bifida was resistant to folic acid treatment, while retinoic acid administration caused severe skeletal defects in the mutant, but none in wild type control animals. The transgene integrated at chromosome 11 band D, in an area of high gene density. The insertion site was located between the transcription start sites of the Rpl23 and Lasp1 genes. LASP1 (an actin binding protein involved in cell migration and survival) was found to be produced in resting and hypertrophic chondrocytes in the vertebrae. In mutant vertebrae, temporal and spatial misexpression of Lasp1 was observed, indicating that alterations in Lasp1 transcription are most likely responsible for the observed phenotype. These data reveal a yet unappreciated role of Lasp1 in chondrocyte differentiation during cartilage to bone transition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19378260     DOI: 10.1387/ijdb.072435nh

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  6 in total

1.  Network correlation analysis revealed potential new mechanisms for neural tube defects beyond folic acid.

Authors:  Xiaoya Gao; Richard H Finnell; Hongyan Wang; Yufang Zheng
Journal:  Birth Defects Res       Date:  2018-05-06       Impact factor: 2.344

2.  Four loci explain 83% of size variation in the horse.

Authors:  Shokouh Makvandi-Nejad; Gabriel E Hoffman; Jeremy J Allen; Erin Chu; Esther Gu; Alyssa M Chandler; Ariel I Loredo; Rebecca R Bellone; Jason G Mezey; Samantha A Brooks; Nathan B Sutter
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

3.  LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas.

Authors:  Cas Vanderheijden; Thomas Vaessen; Youssef Yakkioui; Robert Riedl; Yasin Temel; Koos Hovinga; Govert Hoogland
Journal:  J Neurooncol       Date:  2022-05-04       Impact factor: 4.506

Review 4.  An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.

Authors:  Martin F Orth; Alex Cazes; Elke Butt; Thomas G P Grunewald
Journal:  Oncotarget       Date:  2015-01-01

5.  Proteomic analysis on effectors involved in BMP-2-induced osteogenic differentiation of beagle bone marrow mesenchymal stem cells.

Authors:  Ji-Jie Hu; Ya-Wei Liu; Min-Yi He; Dan Jin; Hui Zhao; Bin Yu
Journal:  Proteome Sci       Date:  2014-03-01       Impact factor: 2.480

6.  Combined culture experiment of mouse bone marrow mesenchymal stem cells and bioceramic scaffolds.

Authors:  Xin Huang; Zhenhao Chen; Guanglei Zhao; Jingsheng Shi; Gangyong Huang; Feiyan Chen; Yibing Wei; Jun Xia; Jie Chen; Siqun Wang
Journal:  Exp Ther Med       Date:  2020-08-27       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.